Ophthalmology 360
  • Conferences
  • Videos
  • Podcasts
  • Quizzes
  • About
    • About Us – Mission
    • Content Awards
    • Media Partners
    • Business Team
    • Brand Ambassadors
    • Photo Contest
    • Industry Council
    • Advisory Board

What are you looking for?

  • Anterior Segment
  • Cataract
  • Cornea and External Disease
  • Diabetic Macular Edema
  • Dry Eye
  • Early Onset Cataracts
  • Exclusives
  • General
  • Geographic Atrophy
  • Glaucoma
  • Industry News
  • Inherited Retinal Disease
  • IOLs
  • Neurotrophic Keratitis
  • Ocular Surface Disease
  • Oculoplastics
  • Optometry
  • Pediatrics
  • Practice Management
  • Presbyopia
  • Refractive Surgery/Vision Correction
  • Residents & Young Ophthalmologists
  • Retina
  • Retina Care 360
  • Retinopathy of Prematurity
  • Spotlight Series
  • The Interventional Glaucoma Project
  • The Ophthalmic Project
  • Trending Topics
2nd Annual Photo Contest - Enter Here!
Ophthalmology 360
  • Conferences
  • Videos
  • Podcasts
  • Quizzes
  • About
    • About Us – Mission
    • Content Awards
    • Media Partners
    • Business Team
    • Brand Ambassadors
    • Photo Contest
    • Industry Council
    • Advisory Board
Home > Oculoplastics > How does thyroid eye disease impact buccal fat pad volume?
  • Oculoplastics

How does thyroid eye disease impact buccal fat pad volume?

Ophthalmology 360

Thyroid eye disease (TED) does not appear to be associated with a significant difference in buccal fat pad (BFP) volume, potentially indicating that TED-related soft-tissue expansion does not affect BFP, according to a study.

In this cohort study, 72 computed tomography (CT) scans of patients with TED (n = 24) and controls (n = 48) were analyzed by 3 independent, blinded observers for the primary outcome of BFP volume. Sample size was determined using an effect size based on published reports of the minimum amount of fat excision needed to notice a clinical difference.

The sample in this study detected a difference as large as 1.5cc with 95% power. There was no statistical difference between TED patients and controls in mean BFP volume. The study used analysis of covariance to adjust for patient factors and found no significant difference between groups. Equivalence testing was significant and showed that the observed difference between groups was less than any clinically meaningful difference. The data suggests a 5% risk of a false negative for an effect size of 1.5cc.

Reference
Osias E, Cale M, Saffari P, et al. Clinical and demographic predictors of buccal fat pad volume in thyroid eye disease. Orbit. 2023;doi: 10.1080/01676830.2023.2192787. Epub ahead of print. PMID: 36974465.

Share

Related Content

  • Oculoplastics

Pain measures may help track treatment response in Graves’ orbitopathy

FDA approves Eysuvis for short-term treatment of dry eye disease
  • Oculoplastics

FDA approves Lumvoa for active and chronic thyroid eye disease

Cornea Update: Corneal Dystrophies & Related Conditions with an Update on Genetic Assessment and Treatment
  • Cornea and External Disease

Preventing complications of superficial keratectomy

  • Oculoplastics

Blepharoplasty candidates prioritize function over aesthetics, survey finds

  • Oculoplastics

Integrating amniotic allografts into modern oculoplastic reconstruction: a practical perspective

  • The Ophthalmic Project

The next generation of amniotic membranes for the treatment of corneal epithelial defects

Share

Editor's Picks

  • Neurotrophic Keratitis

Topical insulin shows real-world benefit in neurotrophic keratopathy

  • Retina

GLP-1 RAs have protective effects against AMD

  • Retina

Four-month injection intervals appear safe for long-term stable nAMD

Advisory Board

Saad Ahmad, MD

Ahmad A. Aref, MD, MBA

Roomasa Channa, MD

David Chow, MD, FRCS(C)

Sally L. Baxter, MD, MSc

Neel R. Desai, MD

Nadia Haqqie, MD

Simon Fung, MD, FRCOphth

Sumit Garg, MD

Ross Lakhanpal, MD, FACS

Sanjai Jalaj, MD

Anton Kolomeyer, MD, PhD

Shan Lin, MD

Steven R. Sarkisian, Jr., MD

See All
Ophthalmology 360

Ophthalmology 360® is a dynamic digital platform dedicated to advancing the field of eye care.

Get to Know Us

  • Home
  • About Us
  • Media Partners
  • Advertising Policy
  • Our Advisory Board

Sign up for our Newsletter

Sign up for our Newsletter to get our newest articles instantly!

  • Privacy Policy
  • Advertising Policy
  • Medical Disclaimer
IHM Logo

2026 Ophthalmology 360 is a trademark of International Healthcare Media, LLC. All rights reserved

  • MedJournal360 Icon
  • RareDisease360 Icon
  • MyHero360 Icon
  • Optometry360 Icon
  • Ophtalmology360 Icon